GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » 3-Year FCF Growth Rate

Mycotopia Therapies (Mycotopia Therapies) 3-Year FCF Growth Rate : -91.30% (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies 3-Year FCF Growth Rate?

Mycotopia Therapies's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -91.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 6 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Mycotopia Therapies was -53.30% per year. The lowest was -91.30% per year. And the median was -72.30% per year.


Competitive Comparison of Mycotopia Therapies's 3-Year FCF Growth Rate

For the Medical Care Facilities subindustry, Mycotopia Therapies's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycotopia Therapies's 3-Year FCF Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mycotopia Therapies's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's 3-Year FCF Growth Rate falls into.



Mycotopia Therapies 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Mycotopia Therapies  (OTCPK:TPIA) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Mycotopia Therapies 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycotopia Therapies (Mycotopia Therapies) Business Description

Traded in Other Exchanges
N/A
Address
18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180
Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336

Mycotopia Therapies (Mycotopia Therapies) Headlines

From GuruFocus

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

By Value_Insider Value_Insider 12-07-2022